AgeStandardized Incidence Rates and Survival of Osteosarcoma in Northern Thailand
- PMID: 27509991
AgeStandardized Incidence Rates and Survival of Osteosarcoma in Northern Thailand
Abstract
Osteosarcoma is a common primary malignant bone tumor in children and adolescents. Recent worldwide average incidences of osteosarcoma in people aged 0 to 24 years were 4.3 and 3.4 per million, respectively, with a ratio of 1.4:1. However, data on the incidence of osteosarcoma in Thailand are limited. This study analyzed the incidence of osteosarcoma in the upper northern region of Thailand, with a population of 5.85 million people (8.9% of the total Thai population), using data for the years 1998 to 2012, obtained from the Chiang Mai Cancer Registry (CMCR) at Chiang Mai University Hospital and the Lampang Cancer Registry (LCR) at the Lampang Cancer Hospital, a total of 144 cases. The overall annual incidence of osteosarcoma was 1.67 per million with a male:female ratio of 1.36:1. Incidences by age group (male and female) at 0 to 24, 25 to 59 and over 60 years were 3.5 (3.9 and 3.0), 0.8 (0.9 and 0.6), and 0.7 (0.8 and 0.5), respectively. The peak incidence occurred at 15 to 19 years for males and at 10 to 14 years for females. The median survival time was 18 months with a 5year survival rate of 43%. Neither the age group nor the 5year interval period of treatment was significantly correlated with survival during the 15year period studied.
Similar articles
-
Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: A series from Chiang Mai University Hospital.Cancer Epidemiol. 2015 Dec;39(6):956-63. doi: 10.1016/j.canep.2015.10.016. Epub 2015 Nov 9. Cancer Epidemiol. 2015. PMID: 26540607
-
Cancer incidence in Thailand, 1995-1997.Asian Pac J Cancer Prev. 2005 Jul-Sep;6(3):276-81. Asian Pac J Cancer Prev. 2005. PMID: 16235986
-
Epidemiologic study of 112 osteosarcomas in Chiang Mai University Hospital, Thailand.J Med Assoc Thai. 2007 Jul;90(7):1400-5. J Med Assoc Thai. 2007. PMID: 17710983
-
Italian cancer figures, report 2012: Cancer in children and adolescents.Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. Epidemiol Prev. 2013. PMID: 23585445 English, Italian.
-
The epidemiology of osteosarcoma.Cancer Treat Res. 2009;152:3-13. doi: 10.1007/978-1-4419-0284-9_1. Cancer Treat Res. 2009. PMID: 20213383 Review.
Cited by
-
Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages.Molecules. 2022 Jul 6;27(14):4345. doi: 10.3390/molecules27144345. Molecules. 2022. PMID: 35889217 Free PMC article.
-
Clinical and radiographic presentation of pelvic sarcoma in children.SICOT J. 2018;4:44. doi: 10.1051/sicotj/2018040. Epub 2018 Oct 19. SICOT J. 2018. PMID: 30339522 Free PMC article.
-
Knockdown of KCNQ1OT1 Suppresses Cell Invasion and Sensitizes Osteosarcoma Cells to CDDP by Upregulating DNMT1-Mediated Kcnq1 Expression.Mol Ther Nucleic Acids. 2019 Sep 6;17:804-818. doi: 10.1016/j.omtn.2019.06.010. Epub 2019 Jun 27. Mol Ther Nucleic Acids. 2019. Retraction in: Mol Ther Nucleic Acids. 2022 May 10;28:589. doi: 10.1016/j.omtn.2022.05.021. PMID: 31454677 Free PMC article. Retracted.
-
Antitumor Effects of Hesperidin and Cisplatin on Human Osteosarcoma Cells Through Inhibiting Proliferation and Inducing Mitochondrial-Mediated Apoptosis.Medicina (Kaunas). 2025 May 23;61(6):960. doi: 10.3390/medicina61060960. Medicina (Kaunas). 2025. PMID: 40572648 Free PMC article.
-
Anal extraskeletal osteosarcoma in a man: a case report and review of the literature.J Med Case Rep. 2020 Apr 20;14(1):51. doi: 10.1186/s13256-020-02365-1. J Med Case Rep. 2020. PMID: 32312303 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources